Stock CLAS.H CLARITAS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Claritas Pharmaceuticals, Inc.

Equities

CLAS.H

CA1806342061

End-of-day quote Toronto S.E.
Other stock markets
 18:00:00 2022-07-18 EDT 		5-day change 1st Jan Change
0.025 CAD -16.67% Intraday chart for Claritas Pharmaceuticals, Inc. -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CLARITAS PHARMACEUTICALS, INC. Stock Claritas Pharmaceuticals, Inc.
 687K - - - - -
MODERNA, INC. Stock Moderna, Inc.
 53.67B -
LONZA GROUP AG Stock Lonza Group AG
 38.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.76B
CELLTRION, INC. Stock Celltrion, Inc.
 27.27B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.91B
  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. Charts Claritas Pharmaceuticals, Inc.
  5. Sector Chart